Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
Muro, K., Van Cutsem, E., Narita, Y., Pentheroudakis, G., Baba, E., Li, J., Ryu, M -H, Zamaniah, W I Wan, Yong, W -P, Yeh, K -H, Kato, K., Lu, Z., Cho, B.C., Nor, I.M., Ng, M., Chen, L -T, Nakajima, T.E., Shitara, K., Kawakami, H., Tsushima, T., Yoshino, T., Lordick, F., Martinelli, E., Smyth, E.C., Arnold, D., Minami, H., Tabernero, J., Douillard, J -Y
Published in Annals of oncology (01.01.2019)
Published in Annals of oncology (01.01.2019)
Get full text
Journal Article
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
Muro, K., Lordick, F., Tsushima, T., Pentheroudakis, G., Baba, E., Lu, Z., Cho, B.C., Nor, I.M., Ng, M., Chen, L -T, Kato, K., Li, J., Ryu, M -H, Zamaniah, W I Wan, Yong, W -P, Yeh, K -H, Nakajima, T.E., Shitara, K., Kawakami, H., Narita, Y., Yoshino, T., Van Cutsem, E., Martinelli, E., Smyth, E.C., Arnold, D., Minami, H., Tabernero, J., Douillard, J -Y
Published in Annals of oncology (01.01.2019)
Published in Annals of oncology (01.01.2019)
Get full text
Journal Article
Sequential expression of putative stem cell markers in gastric carcinogenesis
WANG, T, ONG, C. W, SALTO-TELLEZ, M, SHI, J, SRIVASTAVA, S, YAN, B, CHENG, C. L, YONG, W. P, CHAN, S. L, YEOH, K. G, IACOPETTA, B
Published in British journal of cancer (23.08.2011)
Published in British journal of cancer (23.08.2011)
Get full text
Journal Article
Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)
Javle, M.M., Oh, D.-Y., Ikeda, M., Yong, W.-P., Hsu, K., Lindmark, B., McIntyre, N., Firth, C.
Published in ESMO open (01.02.2022)
Published in ESMO open (01.02.2022)
Get full text
Journal Article
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
Yong, W.P., Goh, B.C., Soo, R.A., Toh, H.C., Ethirajulu, K., Wood, J., Novotny-Diermayr, V., Lee, S.C., Yeo, W.L., Chan, D., Lim, D., Seah, E., Lim, R., Zhu, J.
Published in Annals of oncology (01.11.2011)
Published in Annals of oncology (01.11.2011)
Get full text
Journal Article
A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
Soo, R.A., Wang, L.Z., Tham, L.S., Yong, W.P., Boyer, M., Lim, H.L., Lee, H.S., Millward, M., Liang, S., Beale, P., Lee, S.C., Goh, B.C.
Published in Annals of oncology (01.07.2006)
Published in Annals of oncology (01.07.2006)
Get full text
Journal Article
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group
André, T., Vernerey, D., Im, S.A., Bodoky, G., Buzzoni, R., Reingold, S., Rivera, F., McKendrick, J., Scheithauer, W., Ravit, G., Fountzilas, G., Yong, W.P., Isaacs, R., Österlund, P., Liang, J.T., Creemers, G.J., Rakez, M., Van Cutsem, E., Cunningham, D., Tabernero, J., de Gramont, A.
Published in Annals of oncology (01.02.2020)
Published in Annals of oncology (01.02.2020)
Get full text
Journal Article
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
Tai, W.M., Yong, W.P., Lim, C., Low, L.S., Tham, C.K., Koh, T.S., Ng, Q.S., Wang, W.W., Wang, L.Z., Hartano, S., Thng, C.H., Huynh, H., Lim, K.T., Toh, H.C., Goh, B.C., Choo, S.P.
Published in Annals of oncology (01.12.2016)
Published in Annals of oncology (01.12.2016)
Get full text
Journal Article
Phase Ib study of safety and tolerability of selinexor in Asian patients with advanced solid cancers
Heong, V Y M, Goh, M L, Yong, W P, Soo, R A, Chee, C E, Raghav, S, Goh, B-C, Lee, S C, Lim, J, Wong, A, Tan, D S P
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Updated results from a phase II study of infigratinib (BGJ398), a selective pan-FGFR kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions
Javle, M., Kelley, R.K., Roychowdhury, S., Weiss, K.H., Abou-Alfa, G.K., Macarulla, T., Sadeghi, S., Waldschmidt, D., Zhu, A.X., Goyal, L., Borad, M., Yong, W.P., Borbath, I., El-Khoueiry, A., Philip, P., Moran, S., Ye, Y., Ising, M., Lewis, N., Bekaii-Saab, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
Tai, W.M., Yong, W.P., Lim, C., Low, L.S., Tham, C.K., Koh, T.S., Ng, Q.S., Wang, W.W., Wang, L.Z., Hartono, S., Thng, C.H., Huynh, H., Lim, K.T., Toh, H.C., Goh, B.C., Choo, S.P.
Published in Annals of oncology (01.02.2018)
Published in Annals of oncology (01.02.2018)
Get full text
Journal Article
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
Shitara, K., Fleitas, T., Kawakami, H., Curigliano, G., Narita, Y., Wang, F., Wardhani, S.O., Basade, M., Rha, S.Y., Wan Zamaniah, W.I., Sacdalan, D.L., Ng, M., Yeh, K.H., Sunpaweravong, P., Sirachainan, E., Chen, M.-H., Yong, W.P., Peneyra, J.L., Ibtisam, M.N., Lee, K.-W., Krishna, V., Pribadi, R.R., Li, J., Lui, A., Yoshino, T., Baba, E., Nakayama, I., Pentheroudakis, G., Shoji, H., Cervantes, A., Ishioka, C., Smyth, E.
Published in ESMO open (01.02.2024)
Published in ESMO open (01.02.2024)
Get full text
Journal Article
Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer
Huellner, M W, Hennedige, T P, Winterhalder, R, Zander, T, Venkatesh, S K, Yong, W P, Soo, R A, Seifert, B, Treumann, T C, Strobel, K, Veit-Haibach, P
Published in Cancer imaging (21.05.2012)
Published in Cancer imaging (21.05.2012)
Get full text
Journal Article
1835P Clinical outcome and prognostic factors for Asian patients in phase I clinical trials
Loh, J., Wu, J., Chieng, J., Chan, A., Yong, W-P., Sundar, R., Lee, S.C., Wong, A., Lim, J.S., Tan, D.S., Soo, R., Chng, W.J., Goh, B.C., Tai, B.C., Chee, C.E.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
431PPhase Ib study of safety and tolerability of selinexor in Asian patients with advanced solid cancers
Heong, V Y M, Goh, M L, Yong, W P, Soo, R A, Chee, C E, Raghav, S, Goh, B-C, Lee, S C, Lim, J, Wong, A, Tan, D S P
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
463PEvaluation of pharmacodynamic (PD) biomarkers in advanced cancer patients treated with oxidative phosphorylation (OXPHOS) inhibitor, OPC-317 (OPC)
Eu, J Q, Yadav, K, Lim, Y -C, Hirpara, J, Kong, L R, Ng, Z C, Lee, V K, Lee, S C, Tan, D S, Soo, R A, Chee, C E, Yong, W P, Sundar, R, Lim, J S, Wang, L, Ohi, N, Tsunoda, T, Pervaiz, S, Goh, B -C, Wong, A L
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
559PBevacizumab as adjuvant treatment for colon cancer: Updated results from the AVANT phase III study by the GERCOR group
André, T, Vernerey, D, Im, S -A, Bodoky, G M, Buzzoni, R, Reingold, S, Rivera, F, McKendrick, J, Scheithauer, W, Geva, R, Fountzilas, G, Yong, W P, Isaacs, R, Österlund, P, Liang, J -T, Creemers, G -J, Van Cutsem, E, Cunningham, D, Tabernero, J, De Gramont, A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article